Can a patient with impaired renal function (dialysis patient) take Benadryl (diphenhydramine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Dialysis Patients Take Benadryl?

Dialysis patients can take Benadryl (diphenhydramine), but it should be used with significant caution due to limited safety data, high protein binding that prevents dialytic removal, and increased risk of side effects in this population. 1

Key Safety Considerations

Pharmacokinetic Concerns

  • Diphenhydramine is highly protein-bound to albumin, which severely limits its removal during dialysis 1
  • This high protein binding predisposes patients to accumulation and increased side effects 1
  • The safety profile and appropriate dosing information for diphenhydramine in end-stage kidney disease (ESKD) is notably lacking in the medical literature 1

Clinical Evidence Gap

  • There is a scarcity of studies evaluating diphenhydramine use specifically in dialysis patients 1
  • Dosing recommendations and toxicity thresholds are unknown for this population 1
  • Case reports document diphenhydramine abuse and toxicity from overdose in patients with kidney disease 1, 2

Practical Recommendations

When Diphenhydramine May Be Considered

  • For acute allergic reactions where benefits clearly outweigh risks 1
  • For severe pruritus unresponsive to other interventions 1
  • For dialysis treatment-related complications when no safer alternative exists 1

Safer Alternatives to Consider First

For sedation or anxiety:

  • Lorazepam is a safer benzodiazepine option as it undergoes hepatic glucuronidation to inactive metabolites and does not require dose adjustment in renal disease 3
  • Lorazepam clearance remains unchanged in renal impairment (approximately 85 ml/min in patients vs 71 ml/min in normals) 3

For pain with sedative needs:

  • Acetaminophen 300-600 mg every 8-12 hours as first-line for mild pain 4, 5
  • Fentanyl or buprenorphine for moderate-to-severe pain, as they lack active metabolites and are hepatically metabolized 4, 5

For nausea:

  • Consider alternative antiemetics with established safety profiles in dialysis rather than relying on diphenhydramine's sedative-antiemetic properties 5

Critical Precautions

High-Risk Populations

  • Elderly dialysis patients require extra precautions before diphenhydramine is prescribed 2
  • Patients with residual renal function may experience unpredictable drug accumulation 6, 7

Dosing Strategy If Used

  • Start at the lowest possible dose and increase gradually, following general principles for dialysis patients 7
  • If prescribing once-daily dosing, administer after dialysis when possible 7
  • Monitor closely for anticholinergic side effects including confusion, urinary retention, and excessive sedation 1

Monitoring Requirements

  • Watch for signs of drug accumulation given the inability to remove diphenhydramine through dialysis 1
  • Be vigilant for potential misuse, as diphenhydramine abuse has been reported in this population 1

Common Pitfalls to Avoid

  • Do not assume standard dosing is safe - the lack of dialytic clearance means standard doses may lead to accumulation 1
  • Do not rely on dialysis to remove excess drug - high protein binding prevents effective removal during hemodialysis 1
  • Do not overlook safer alternatives - medications like lorazepam have better-established safety profiles in renal disease 3
  • Do not prescribe without considering the patient's complete medication list - polypharmacy increases anticholinergic burden 7

References

Research

Diphenhydramine Use in End-Stage Kidney Disease.

American journal of therapeutics, 2021

Research

Diphenhydramine and acute kidney injury.

P & T : a peer-reviewed journal for formulary management, 2013

Research

Effect of renal impairment and hemodialysis on lorazepam kinetics.

Clinical pharmacology and therapeutics, 1984

Guideline

Safest Pain Medications for Patients on Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safe Medication Use in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prescribing for patients on dialysis.

Australian prescriber, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.